Trexquant Investment’s Theravance Biopharma TBPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.73M | Sell |
156,930
-8,494
| -5% | -$93.7K | 0.02% | 930 |
|
2025
Q1 | $1.48M | Buy |
165,424
+14,341
| +9% | +$128K | 0.02% | 970 |
|
2024
Q4 | $1.42M | Buy |
151,083
+50,826
| +51% | +$478K | 0.02% | 982 |
|
2024
Q3 | $808K | Buy |
100,257
+66,735
| +199% | +$538K | 0.01% | 1110 |
|
2024
Q2 | $284K | Buy |
+33,522
| New | +$284K | ﹤0.01% | 1374 |
|
2023
Q1 | – | Sell |
-18,705
| Closed | -$210K | – | 1763 |
|
2022
Q4 | $210K | Buy |
+18,705
| New | +$210K | 0.01% | 1228 |
|
2022
Q1 | – | Sell |
-20,729
| Closed | -$229K | – | 1719 |
|
2021
Q4 | $229K | Buy |
+20,729
| New | +$229K | 0.01% | 1071 |
|
2020
Q4 | – | Sell |
-13,167
| Closed | -$195K | – | 1473 |
|
2020
Q3 | $195K | Buy |
13,167
+2,041
| +18% | +$30.2K | 0.01% | 1085 |
|
2020
Q2 | $234K | Buy |
+11,126
| New | +$234K | 0.02% | 990 |
|
2016
Q4 | – | Sell |
-5,995
| Closed | -$217K | – | 1127 |
|
2016
Q3 | $217K | Sell |
5,995
-6,061
| -50% | -$219K | 0.05% | 606 |
|
2016
Q2 | $274K | Buy |
+12,056
| New | +$274K | 0.04% | 689 |
|
2015
Q4 | – | Sell |
-55,000
| Closed | -$604K | – | 1251 |
|
2015
Q3 | $604K | Buy |
+55,000
| New | +$604K | 0.05% | 645 |
|